Related Experiment Video
Updated: May 3, 2026
High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
Published on: July 29, 2011
Recent advances in understanding the roles of T cells in atrial fibrillation
Jiu Pu1,2,3,4,5, Yimei Du6,7,8,9,10
1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Insights
T cells play a key role in atrial fibrillation (AF). Specific T cell subsets and their inflammatory factors contribute to AF pathogenesis, suggesting potential new therapeutic targets for this common arrhythmia.
Area of Science:
- Immunology
- Cardiology
- Molecular Biology
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia linked to serious cardiovascular events.
- Emerging evidence implicates T lymphocytes in the pathophysiology of AF.
Purpose of the Study:
- To elucidate the specific T cell subsets and mechanisms involved in AF.
- To identify potential therapeutic targets for AF based on T cell-mediated pathways.
Main Methods:
- Analysis of T cell populations (CD4+CD28null, Th17/Treg, CD8+) in AF patients.
- Assessment of inflammatory markers (TNF-α, IL-17) and cytotoxic proteins (perforin, granzymes).
- Investigation of T cell interactions with atrial myocytes and cardiac tissue.
Main Results:
- Elevated levels of specific T cell subsets and related markers were observed in AF patients.
- These T cells release inflammatory and cytotoxic factors impacting atrial myocytes.
- T cell activity contributes to atrial fibrosis, inflammation, oxidative stress, and myocyte apoptosis.
Conclusions:
- T cell-mediated mechanisms are integral to AF development and progression.
- Targeting specific T cell subsets or their inflammatory mediators may offer novel therapeutic strategies for AF.
- Further research into T cell-driven pathways is crucial for advancing AF treatment.
Abstract:
Atrial fibrillation (AF) is a common arrhythmia associated with severe outcomes like heart failure and stroke. Recent studies highlight the crucial role of T in AF. Clinical studies have observed elevated levels of CD4+CD28null T cells, Th17/Treg cells, CD8+ cells, and related markers in the peripheral blood or atrial tissue of AF patients, correlating with disease severity and cardiovascular events. These T cell subsets contribute to AF through: (1) releasing inflammatory factors like TNF-α and IL-17 which affect calcium homeostasis and electrical activity in atrial myocytes and/or promote atrial fibrosis; (2) recruiting inflammatory cells such as macrophages, causing local inflammation, oxidative stress, and atrial remodeling; (3) secreting cytotoxic proteins like perforin and granzymes, inducing apoptosis in atrial myocytes and affecting their action potentials; (4) direct contact, influencing atrial myocyte electrophysiology. Understanding these T cell-mediated mechanisms may uncover new therapeutic targets for AF.
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
Some...
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...